Tirzepatide + B12
Dual GLP-1/GIP weight management.
Tirzepatide is a dual GLP-1 and GIP receptor agonist prescribed for weight management. This is a compounded preparation that also contains vitamin B12.
How it works
Tirzepatide activates both GLP-1 and GIP receptors, which reduces appetite signalling and improves how the body handles glucose.
Benefits
- Weekly dual GLP-1 and GIP treatment
- Reduces appetite signalling
- Supports insulin sensitivity
- Supports glucose metabolism
- Physician-dosed and titrated
Dosing
As prescribed. Your physician sets the amount and the schedule on the prescription that comes with your order.
Contraindications
- Personal or family history of thyroid cancer
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- Pancreatitis
- Severe GI disease
- Pregnancy
Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Medications only issued when clinically appropriate after provider evaluation.